147 related articles for article (PubMed ID: 38045626)
1. Patient values and preferences regarding communicating risk versus benefit of benzodiazepine initiation: A cross-sectional survey study.
Chahal K; Glass M; Falk J; Singer A; Leong C
Health Sci Rep; 2023 Dec; 6(12):e1597. PubMed ID: 38045626
[TBL] [Abstract][Full Text] [Related]
2. Role of community pharmacists in the detection of potentially inappropriate benzodiazepines prescriptions for insomnia.
Urru SA; Pasina L; Minghetti P; Giua C
Int J Clin Pharm; 2015 Dec; 37(6):1004-8. PubMed ID: 26198541
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia.
Morin CM; Bastien C; Guay B; Radouco-Thomas M; Leblanc J; Vallières A
Am J Psychiatry; 2004 Feb; 161(2):332-42. PubMed ID: 14754783
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial.
Baillargeon L; Landreville P; Verreault R; Beauchemin JP; Grégoire JP; Morin CM
CMAJ; 2003 Nov; 169(10):1015-20. PubMed ID: 14609970
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey.
Reid Finlayson AJ; Macoubrie J; Huff C; Foster DE; Martin PR
Ther Adv Psychopharmacol; 2022; 12():20451253221082386. PubMed ID: 35499041
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepine use risk: Understanding patient specific risk perceptions and medication beliefs.
Sake FT; Wong K; Bartlett DJ; Saini B
Res Social Adm Pharm; 2019 Nov; 15(11):1317-1325. PubMed ID: 30639048
[TBL] [Abstract][Full Text] [Related]
8. Enduring neurological sequelae of benzodiazepine use: an Internet survey.
Huff C; Finlayson AJR; Foster DE; Martin PR
Ther Adv Psychopharmacol; 2023; 13():20451253221145561. PubMed ID: 36760692
[TBL] [Abstract][Full Text] [Related]
9. A Pharmacist-Physician Collaboration to Optimize Benzodiazepine Use for Anxiety and Sleep Symptom Control in Primary Care.
Furbish SML; Kroehl ME; Loeb DF; Lam HM; Lewis CL; Nelson J; Chow Z; Trinkley KE
J Pharm Pract; 2017 Aug; 30(4):425-433. PubMed ID: 27480874
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.
Baandrup L; Ebdrup BH; Rasmussen JØ; Lindschou J; Gluud C; Glenthøj BY
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011481. PubMed ID: 29543325
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepines and risk of all cause mortality in adults: cohort study.
Patorno E; Glynn RJ; Levin R; Lee MP; Huybrechts KF
BMJ; 2017 Jul; 358():j2941. PubMed ID: 28684397
[No Abstract] [Full Text] [Related]
12. Benzodiazepine usage and patient preference for alternative therapies: A descriptive study.
Sake FT; Wong K; Bartlett DJ; Saini B
Health Sci Rep; 2019 May; 2(5):e116. PubMed ID: 31139756
[TBL] [Abstract][Full Text] [Related]
13. Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey.
Ritvo AD; Foster DE; Huff C; Finlayson AJR; Silvernail B; Martin PR
PLoS One; 2023; 18(6):e0285584. PubMed ID: 37384788
[TBL] [Abstract][Full Text] [Related]
14. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
Mercier-Guyon C; Chabannes JP; Saviuc P
Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
[TBL] [Abstract][Full Text] [Related]
15. Treatment Preferences for Internet-Based Cognitive Behavioral Therapy for Insomnia in Japan: Online Survey.
Sato D; Sutoh C; Seki Y; Nagai E; Shimizu E
JMIR Form Res; 2019 May; 3(2):e12635. PubMed ID: 31094319
[TBL] [Abstract][Full Text] [Related]
16. Application of a diazepam milligram equivalency algorithm to assess benzodiazepine dose intensity in Rhode Island in 2018.
Borrelli EP; Bratberg J; Hallowell BD; Greaney ML; Kogut SJ
J Manag Care Spec Pharm; 2022 Jan; 28(1):58-68. PubMed ID: 34949119
[No Abstract] [Full Text] [Related]
17. Association of Benzodiazepine Treatment for Sleep Disorders With Drug Overdose Risk Among Young People.
Bushnell GA; Gerhard T; Keyes K; Hasin D; Cerdá M; Olfson M
JAMA Netw Open; 2022 Nov; 5(11):e2243215. PubMed ID: 36413369
[TBL] [Abstract][Full Text] [Related]
18. Preferences for Electronic Modes of Communication Among Older Primary Care Patients: Cross-sectional Survey.
Fridman I; Smalls A; Fleming P; Elston Lafata J
JMIR Form Res; 2023 May; 7():e40709. PubMed ID: 37223979
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings.
Denis C; Fatséas M; Lavie E; Auriacombe M
Cochrane Database Syst Rev; 2006 Jul; (3):CD005194. PubMed ID: 16856084
[TBL] [Abstract][Full Text] [Related]
20. Withdrawing benzodiazepines in primary care.
Lader M; Tylee A; Donoghue J
CNS Drugs; 2009; 23(1):19-34. PubMed ID: 19062773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
